野村发表研究报告指，京东健康(06618.HK) 上半年收入按年增长16%，略低于市场预期1%，主要由于跨境营养品监管收紧导致广告收入较弱。然而，经调整经营溢利按年大增40%至35亿元人民币，经营溢利率升1.5个百分点至8.5%，主要受惠于供应链效率提升带动毛利率扩张，以及规模经济优化履约费用率。目标价由67港元下调至60港元，维持“买入”评级。(ad/u)(港股报价延迟最少十五分钟。沽空资料截至...
Source Link野村发表研究报告指，京东健康(06618.HK) 上半年收入按年增长16%，略低于市场预期1%，主要由于跨境营养品监管收紧导致广告收入较弱。然而，经调整经营溢利按年大增40%至35亿元人民币，经营溢利率升1.5个百分点至8.5%，主要受惠于供应链效率提升带动毛利率扩张，以及规模经济优化履约费用率。目标价由67港元下调至60港元，维持“买入”评级。(ad/u)(港股报价延迟最少十五分钟。沽空资料截至...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.